Sharps Technology, Inc. (NASDAQ:STSS) Sees Significant Drop in Short Interest

Sharps Technology, Inc. (NASDAQ:STSS) was the target of a large decline in short interest in November. As of November 30th, there was short interest totalling 40,800 shares, a decline of 32.0% from the November 15th total of 60,000 shares. Approximately 2.3% of the company’s stock are sold short. Based on an average trading volume of 185,800 shares, the short-interest ratio is currently 0.2 days.

Institutional Trading of Sharps Technology

An institutional investor recently bought a new position in Sharps Technology stock. Garden State Investment Advisory Services LLC purchased a new position in Sharps Technology, Inc. (NASDAQ:STSS) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 172,909 shares of the company’s stock, valued at approximately $26,000. Garden State Investment Advisory Services LLC owned 9.61% of Sharps Technology as of its most recent SEC filing. 17.17% of the stock is currently owned by institutional investors.

Sharps Technology Stock Performance

Shares of Sharps Technology stock traded up $0.05 during midday trading on Friday, reaching $2.04. 99,088 shares of the company’s stock traded hands, compared to its average volume of 209,400. Sharps Technology has a 52 week low of $1.70 and a 52 week high of $18.15. The firm has a 50 day moving average of $2.83. The stock has a market capitalization of $3.67 million, a P/E ratio of -0.25 and a beta of 1.37.

Sharps Technology Company Profile

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.